Trial intelligence / Profile preview

Evaluation of CYP2C9 Activity With Dried Blood Spots

NCT01026714Phase 2Completed

Start
Nov 2009
Primary completion
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of flurbiprofen. Started Nov 2009; status: completed.

02

Drugs

flurbiprofen

Beyond the preview

Go deeper on NCT01026714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01026714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call